Healthcare provider profile · identity verified

Jonathan Kersh

Internal Medicine · POST FALLS, ID · NPI 1710412770

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	496	158
Levothyroxine Sodium	Levothyroxine Sodium	447	121
Rosuvastatin Calcium	Rosuvastatin Calcium	356	109
Losartan Potassium	Losartan Potassium	323	103
Omeprazole	Omeprazole	305	100
Lisinopril	Lisinopril	286	80
Amlodipine Besylate	Amlodipine Besylate	278	76
Metoprolol Succinate	Metoprolol Succinate	272	71
Duloxetine Hcl	Duloxetine Hcl	263	63
Gabapentin	Gabapentin	229	72
Hydrochlorothiazide	Hydrochlorothiazide	205	68
Tamsulosin Hcl	Tamsulosin Hcl	196	58
Metformin Hcl Er	Metformin Hcl	161	52
Jardiance	Empagliflozin	144	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	135	29
Metformin Hcl	Metformin Hcl	132	43
Eliquis	Apixaban	128	37
Trazodone Hcl	Trazodone Hcl	127	38
Sertraline Hcl	Sertraline Hcl	117	33
Tramadol Hcl	Tramadol Hcl	117	35
Pantoprazole Sodium	Pantoprazole Sodium	113	35
Albuterol Sulfate Hfa	Albuterol Sulfate	100	43
Allopurinol	Allopurinol	100	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	97	26
Carvedilol	Carvedilol	95	25
Simvastatin	Simvastatin	89	30
Alprazolam	Alprazolam	86	22
Ozempic	Semaglutide	86	22
Pregabalin	Pregabalin	84	20
Escitalopram Oxalate	Escitalopram Oxalate	82	30
Potassium Chloride	Potassium Chloride	82	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	79	20
Fluoxetine Hcl	Fluoxetine Hcl	78	24
Metoprolol Tartrate	Metoprolol Tartrate	74	20
Furosemide	Furosemide	71	21
Clopidogrel	Clopidogrel Bisulfate	67	18
Alendronate Sodium	Alendronate Sodium	58	16
Estradiol	Estradiol	58	17
Mirtazapine	Mirtazapine	55	16
Synthroid	Levothyroxine Sodium	54	17
Montelukast Sodium	Montelukast Sodium	52	15
Pravastatin Sodium	Pravastatin Sodium	52	17
Buspirone Hcl	Buspirone Hcl	51	13
Ezetimibe	Ezetimibe	50	15
Hydroxyzine Hcl	Hydroxyzine Hcl	47	19
Telmisartan	Telmisartan	47	15
Finasteride	Finasteride	45	15
Meloxicam	Meloxicam	45	16
Famotidine	Famotidine	43	13
Quetiapine Fumarate	Quetiapine Fumarate	43	12
Spironolactone	Spironolactone	43	17
Citalopram Hbr	Citalopram Hydrobromide	42	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	13
Fluticasone Propionate	Fluticasone Propionate	41	19
Valacyclovir	Valacyclovir Hcl	40	15
Bupropion Xl	Bupropion Hcl	38	13
Donepezil Hcl	Donepezil Hcl	36	15
Irbesartan	Irbesartan	36	suppressed
Glipizide Er	Glipizide	34	16
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Baclofen	Baclofen	33	suppressed
Celecoxib	Celecoxib	33	suppressed
Azelastine Hcl	Azelastine Hcl	32	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	12
Propranolol Hcl	Propranolol Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	28	suppressed
Sucralfate	Sucralfate	28	suppressed
Prednisone	Prednisone	27	11
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Spiriva Respimat	Tiotropium Bromide	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Arnuity Ellipta	Fluticasone Furoate	25	suppressed
Atenolol	Atenolol	24	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Azithromycin	Azithromycin	21	18
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Repatha Sureclick	Evolocumab	21	suppressed
Armour Thyroid	Thyroid,pork	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	17
Nystatin	Nystatin	18	11
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Torsemide	Torsemide	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Temazepam	Temazepam	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Diazepam	Diazepam	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Ursodiol	Ursodiol	14	suppressed
Linzess	Linaclotide	13	suppressed
Ubrelvy	Ubrogepant	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Testosterone	Testosterone	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	11
Valsartan	Valsartan	12	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Repatha Syringe	Evolocumab	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error